Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1068

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9A
Chunk 1068
---
 (170,000) 
    $5  
     -  
    $- 
  
    Outstanding
    as December 31, 2023 
     1,215,001  
    $5.29  
     8.7  
    $- 
  
    Options
    granted  
     3,599,000  
    $1.15  
     -  
    $- 
  
    Expired 
     (268,886) 
    $5.05  
     -  
    $- 
  
    Forfeitures 
     (309,449) 
    $4.68  
     -  
    $- 
  
    Outstanding
                                            as December 31, 2024  
     4,235,666  
    $1.83  
     9.2  
    $135,200 
  
    Exercisable,
                                            December 31, 2024  
     2,348,720  
    $2.23  
     8.6  
    $120,886 

Key
assumptions used to value stock options during the year ended December 31, 2024 are as follows:

Schedule of Key Assumptions Used to Value Stock Options

    Expected
    volatility 
     58.46-152.45% 
  
    Risk-free
    interest rate 
     3.49-4.56% 
  
    Exercise Price 
     $
                                            0.71 - $1.57 
  
    Expected
    term (years) 
     5-5.5
                                            years 
  
    Dividend
    yield 
     - 

During
the year ended December 31, 2024, a total of 500,000 restricted stock units (“RSU”), with an aggregate fair market value
of approximately $0.6 million were granted to the Company’s Chief Executive Officer under the 2022 Omnibus Incentive Plan. These
RSU’s vest as follows: (i) 50% on February 12, 2025 (ii) 50% at 6-month anniversary of date of grant. The awards were fair valued
using the closing price of the stock of $1.19 on December 6th, 2024.

As
of December 31, 2024, there